Profile
Scott Carmer served as President, Chief Executive Officer & Director at NexImmune, Inc. from 2018 to 2022.
Prior to that, he was the Chief Executive Officer at Orgenesis Maryland, Inc. from 2014 to 2016.
He also held positions at Amgen, Inc., Genentech, Inc., MedImmune LLC, and GlaxoSmithKline, Inc. Mr. Carmer received his undergraduate degree from the University of Kentucky.
Former positions of Scott Carmer
| Companies | Position | End |
|---|---|---|
| NEXIMMUNE, INC. | Chief Executive Officer | 2022-02-11 |
Orgenesis Maryland, Inc.
 Orgenesis Maryland, Inc. Pharmaceuticals: MajorHealth Technology Part of Orgenesis, Inc., Orgenesis Maryland, Inc. develops a novel therapeutic for the treatment of diabetes. The private company is based in Germantown, MD. | Chief Executive Officer | 2016-11-17 |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Corporate Officer/Principal | - |
| AMGEN INC. | Corporate Officer/Principal | - |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | - |
Training of Scott Carmer
| University of Kentucky | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| NEXIMMUNE, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
Orgenesis Maryland, Inc.
Orgenesis Maryland, Inc. Pharmaceuticals: MajorHealth Technology Part of Orgenesis, Inc., Orgenesis Maryland, Inc. develops a novel therapeutic for the treatment of diabetes. The private company is based in Germantown, MD. | Health Technology |
- Stock Market
- Insiders
- Scott Carmer
